Fmoc-D-leucinol

Fmoc-D-leucinol is an Fmoc-protected D-leucinol amino alcohol in which the leucine-derived side chain is retained while the α-amino functionality is masked as an N-(9H-fluoren-9-ylmethoxycarbonyl) carbamate and the corresponding alcohol remains available for further chemistry. The D stereocenter at the amino alcohol framework provides defined chiral recognition in peptide and peptidomimetic contexts, while the Fmoc group enables standard base-labile deprotection compatible with solid-phase peptide synthesis. The molecule's primary alcohol and hydrophobic isobutyl side chain support selective derivatization (e.g., ether/ester formation) and influence solubility and coupling behavior in synthetic sequences. The combination of protected amine and free hydroxyl makes Fmoc-D-leucinol a practical chiral intermediate for constructing amino alcohol motifs, stereochemically defined peptide analogs, and downstream functional scaffolds.

1. Peptide Synthesis

Fmoc-D-leucinol is applied in peptide synthesis workflows requiring amino alcohol building blocks, where the Fmoc carbamate supports iterative N-terminal protection and base-mediated Fmoc removal to enable sequential coupling. The free hydroxyl at the leucinol position can be preserved as a hydrogen-bonding handle or selectively protected during chain assembly to avoid side reactions under coupling conditions. The D configuration at the amino alcohol center allows incorporation of stereodefined residues that can modulate backbone conformation and protease resistance in peptidomimetic designs. Downstream, the resulting peptide or peptide-like products can be used to generate libraries of amino alcohol-containing analogs for method development and scaffold exploration in peptide chemistry.

2. Peptidomimetics

Fmoc-D-leucinol is used in peptidomimetic construction where amino alcohol functionality serves as a conformationally informative replacement for an amide or as a handle for intramolecular hydrogen bonding. The leucine-derived hydrophobic side chain and the chiral amino alcohol stereocenter can be mapped into SAR studies to probe how stereochemistry and polar functionality affect binding-site interactions. The Fmoc-protected amine enables controlled incorporation into longer sequences or fragment-based assemblies, while the hydroxyl can be transformed into ethers, esters, or other oxygen-linked substituents to tune polarity. Peptidomimetic intermediates derived from Fmoc-D-leucinol can also feed into medicinal chemistry programs focused on structure-guided optimization of peptide-like scaffolds.

3. Side-Chain Functionalization

Fmoc-D-leucinol is employed for side-chain functionalization strategies that leverage the primary alcohol to introduce additional reactive groups without disturbing the protected amine. The hydroxyl can undergo selective derivatization to generate ester, carbonate, or ether derivatives, enabling orthogonal protection schemes that coexist with Fmoc chemistry during multistep synthesis. The D-leucinol stereochemistry helps maintain stereochemical integrity through downstream transformations, which is important when producing chiral amino acid derivatives for stereocontrolled library generation. Functionalized derivatives prepared from Fmoc-D-leucinol can serve as intermediates for further coupling, immobilization, or conjugation chemistry in synthetic organic and chemical biology research.

4. Chemical Biology Probes

Fmoc-D-leucinol is suitable for chemical biology probe development where amino alcohol residues provide a stable, stereodefined motif for labeling, affinity reagents, or enzyme-interaction studies. The Fmoc group supports controlled assembly of probe precursors, while the free hydroxyl enables attachment of linkers, tags, or solubilizing groups through oxygen-based connectivity. The leucine hydrophobic character and the D stereocenter can influence recognition by biomolecular targets by shaping local sterics and hydrogen-bonding patterns. Probe constructs generated from Fmoc-D-leucinol can be used as research tools to investigate biomolecular interfaces, validate binding hypotheses, and support mechanistic studies involving peptide-like ligands.

5. Pharmaceutical Intermediate Preparation

Fmoc-D-leucinol is used as a chiral intermediate in fine chemical synthesis for producing protected amino alcohol fragments that can be carried into pharmaceutical intermediate routes. The Fmoc-protected amine provides a robust handle for controlled deprotection during manufacturing-relevant sequence design, while the retained hydroxyl enables downstream conversion to activated intermediates for further bond formation. The leucine-derived side chain supports incorporation into drug-like peptidomimetic scaffolds where hydrophobic patterning and stereochemical control are required. Intermediates derived from Fmoc-D-leucinol can be integrated into scalable synthetic strategies for generating stereochemically defined building blocks used in medicinal chemistry and process chemistry development.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum